The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
Part of paid clinical trials in Worcester, Massachusetts.
- Sponsor
- MCPHS University
- Study ID
- NCT06593405
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 100 Years
- Healthy Volunteers
- Accepted
Interventions
- occupational therapy interventions for low vision care — COMBINATION_PRODUCTOccupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.
Study Details
The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.
Key Dates
- Start date
- Apr 22, 2025
- Status verified
- May 2026
- Primary completion
- Dec 5, 2026
- Completion
- Dec 5, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Receiving OT interventionsAll participants will receive all OT interventions
Primary Outcome Measure
Revised Self Report Assessment of Functional Visual [ Time Frame: Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later ]
Central Contacts
- Michelle Dowling, OTD508-373-5851
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MCPHS 10 Lincoln Square | Worcester | Massachusetts | 01608 | Michelle Dowling, Clinical Doctorate (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Worcester, MA
Related Studies
- A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationPHASE1 · Recruiting · Astellas Institute for Regenerative Medicine · Phoenix, Arizona
- Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMDPHASE2 · Recruiting · Massachusetts Eye and Ear Infirmary · Boston, Massachusetts
- Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMDRecruiting · VisionCare, Inc. · Loma Linda, California
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland